Home › Companies › ADMA BIOLOGICS INC. › 2024-2025

ADMA BIOLOGICS INC. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and ADMA BIOLOGICS INC.’s Form 8-K, filed 2025-06-04 (Item 5.07 on EDGAR). Page generated 02 October 2026.

8Reported items
363Asset managers
2,784Fund votes
2025-06-04Meeting date

Proxy season: 2024-2025 2025-2026

Explore ADMA BIOLOGICS INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by ADMA BIOLOGICS INC.

These tallies are ADMA BIOLOGICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-06-04 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

ADMA BIOLOGICS INC. — official shareholder meeting results, meeting held 2025-06-04
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Outcome
Elect Director: Jerrold B. Grossman D.P.S.	165,120,823	--	--	16,472,081	23,427,635	Majority: yes
Elect Director: Lawrence P. Guiheen	133,835,725	--	--	47,757,179	23,427,635	Majority: yes
Proposal 2: The ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025;	204,623,833	269,649	127,057	--	--	Majority: yes
Proposal 3: The approval of, on a non-binding, advisory basis, the compensation of the Company's named executive officers ("Say-on-Pay"); and	161,456,980	19,869,072	266,852	--	23,427,635	Majority: yes

Source: ADMA BIOLOGICS INC., Form 8-K, filed with the SEC on 2025-06-04 — read the filing on EDGAR.

How asset managers voted at the ADMA BIOLOGICS INC. 2024-2025 meeting

Each item below shows how the 363 asset managers that disclosed a ADMA BIOLOGICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of ADMA BIOLOGICS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 10 wordings of this item as funds reported it.

89% Majority: yes · of votes cast

FOR 89%11%

FOR: 161,456,980AGAINST: 19,869,072

ADMA BIOLOGICS INC.’s own tally for this item (“Proposal 3: The approval of, on a non-binding, advisory basis, the compensation of the Company's named executive officers ("Say-on-Pay"); and”): 161,456,980 for, 19,869,072 against, per its Form 8-K filed 2025-06-04 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 238,532,252 outstanding shares: 68% for, 8% against (76% of the company cast a for/against vote).

The 361 asset managers below cast 87% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.

FOR 87%13%

FOR: 86.8%AGAINST: 13.1%ABSTAIN: 0.1%NOT VOTED: 0.0%

Largest asset managers voting on “To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.” at ADMA BIOLOGICS INC., 2024-2025
Asset manager	For	Against	Abstain	Vote
BlackRock	34,136,118	73,823	0	For
Invesco	0	17,593,868	0	Against
Vanguard	17,111,774	12,347	1	For
State Street	16,950,408	5,224	0	For
Fidelity	10,895,786	0	0	For
GEODE CAPITAL MANAGEMENT, LLC	5,690,680	0	0	For
Nuveen	5,574,686	0	0	For
American Century	0	5,269,581	0	Against
Allspring	5,085,857	0	0	For
Charles Schwab	4,772,381	0	0	For
T. Rowe Price	3,823,426	0	0	For
Thrivent	3,716,518	0	0	For
TIAA	3,467,810	0	0	For
OBERWEIS ASSET MANAGEMENT INC/	3,359,150	0	0	For
OBERWEIS FUNDS	3,342,600	0	0	For
Dimensional	3,237,518	0	0	For
J O HAMBRO CAPITAL MANAGEMENT LTD	2,918,944	0	0	For
Putnam	2,915,106	0	0	For
Northern Trust	2,376,776	0	0	For
Two Sigma	2,334,017	0	0	For
B Group, Inc.	2,316,064	0	0	For
Federated Hermes	2,208,781	11,443	0	For
Renaissance	2,131,647	0	0	For
Russell Investments	1,961,434	0	0	For
DRIEHAUS CAPITAL MANAGEMENT LLC	1,703,057	0	0	For

Showing the 25 largest of 361 asset managers. See all 361 in the interactive database.

2. To determine, on a non-binding, advisory basis, the frequency of future advisory votes on the compensation of the Company's named executive officers.

SECTION 14A SAY-ON-PAY VOTES

Combines 4 wordings of this item as funds reported it.

99.6% fund support · no official result

ONE YEAR 70%1 YEAR 27%

The 344 asset managers below cast 99.6% of the shares they voted on this item FOR (1,662,866 for, 5,670 against).

FOR: 1,662,866 (0.8%)AGAINST: 5,670 (0.0%)ABSTAIN: 34,420 (0.0%)ONE YEAR: 144,999,769 (70.0%)1 YEAR: 56,700,795 (27.4%)THREE YEARS: 3,286,981 (1.6%)3 YEARS: 190,088 (0.1%)1-YEAR: 133,185 (0.1%)1: 105,000 (0.1%)3 YEAR: 3,017 (0.0%)NOT VOTED: 45 (0.0%)2 YEAR: 2 (0.0%)3.0: 1 (0.0%)1.0: 0 (0.0%)2.0: 0 (0.0%)

Largest asset managers voting on “To determine, on a non-binding, advisory basis, the frequency of future advisory votes on the compensation of ” at ADMA BIOLOGICS INC., 2024-2025
Asset manager	For	Against	Abstain	Withheld	Vote
BlackRock	0	0	0	0	1 Year
Invesco	0	0	0	0	One Year
Vanguard	0	0	0	0	One Year
State Street	0	0	0	0	One Year
Fidelity	0	0	0	0	One Year
GEODE CAPITAL MANAGEMENT, LLC	0	0	0	0	One Year
Nuveen	0	0	0	0	One Year
American Century	0	0	0	0	One Year
Allspring	0	0	0	0	One Year
Charles Schwab	0	0	0	0	1 Year
T. Rowe Price	0	0	0	0	One Year
Thrivent	0	0	0	0	One Year
TIAA	0	0	0	0	One Year
OBERWEIS ASSET MANAGEMENT INC/	0	0	0	0	One Year
OBERWEIS FUNDS	0	0	0	0	One Year
Dimensional	0	0	0	0	Three Years
J O HAMBRO CAPITAL MANAGEMENT LTD	0	0	0	0	One Year
Putnam	0	0	0	0	One Year
Northern Trust	0	0	0	0	1 Year
Two Sigma	0	0	0	0	One Year
Federated Hermes	0	0	0	0	1 Year
Renaissance	0	0	0	0	One Year
Russell Investments	0	0	0	0	1 Year
DRIEHAUS CAPITAL MANAGEMENT LLC	0	0	0	0	One Year
Ranger Investment Management, L.P.	0	0	0	0	One Year

Showing the 25 largest of 344 asset managers. See all 344 in the interactive database.

3. To ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.

AUDIT-RELATEDMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

99.8% Majority: yes · of votes cast

FOR 99.8%

FOR: 204,623,833AGAINST: 269,649

ADMA BIOLOGICS INC.’s own tally for this item (“Proposal 2: The ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025;”): 204,623,833 for, 269,649 against, per its Form 8-K filed 2025-06-04 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 238,532,252 outstanding shares: 86% for, 0.2% against (86% of the company cast a for/against vote).

The 114 asset managers below cast 99.9% of the shares they voted on this item FOR (105,067,550 for, 0 against).

FOR 99.9%

FOR: 105,067,550 (100.0%)AGAINST: 0 (0.0%)ABSTAIN: 34,420 (0.0%)

Largest asset managers voting on “To ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the f” at ADMA BIOLOGICS INC., 2024-2025
Asset manager	For	Abstain	Vote
BlackRock	26,117,195	0	For
Vanguard	16,334,134	0	For
Fidelity	7,532,522	0	For
Invesco	7,437,984	0	For
State Street	6,220,503	0	For
TIAA	3,467,129	0	For
OBERWEIS FUNDS	3,342,600	0	For
Dimensional	2,659,880	0	For
American Century	2,409,824	0	For
Charles Schwab	2,292,684	0	For
Allspring	2,177,517	0	For
Thrivent	1,851,036	0	For
T. Rowe Price	1,577,442	0	For
Jackson National	1,571,372	0	For
Lord Abbett	1,419,766	0	For
Calamos	1,408,078	0	For
Putnam	1,366,764	0	For
Federated Hermes	1,074,813	0	For
Waddell & Reed	897,194	0	For
Brighthouse	742,974	34,420	For
Nuveen	730,657	0	For
Equitable	621,123	0	For
Royce	612,241	0	For
Voya	611,399	0	For
Columbia Threadneedle	579,761	0	For

Showing the 25 largest of 114 asset managers. See all 114 in the interactive database.

4. To elect the following Class III directors for a term expiring at the 2028 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Lawrence P. Guiheen

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

74% Majority: yes · of votes cast

FOR 74%WITHHELD 26%

FOR: 133,835,725WITHHELD: 47,757,179

ADMA BIOLOGICS INC.’s own tally for this item (“Elect Director: Lawrence P. Guiheen”): 133,835,725 for, 47,757,179 withheld, per its Form 8-K filed 2025-06-04 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 238,532,252 outstanding shares: 56% for, 20% withheld (76% of the company cast a for/withheld vote).

The 113 asset managers below cast 100% of the shares they voted on this item FOR (78,064,206 for, 0 against).

FOR 75%ABSTAIN 25%

FOR: 78,064,206 (74.5%)ABSTAIN: 26,695,935 (25.5%)

Largest asset managers voting on “To elect the following Class III directors for a term expiring at the 2028 Annual Meeting of Stockholders or u” at ADMA BIOLOGICS INC., 2024-2025
Asset manager	For	Abstain	Vote
BlackRock	25,682,132	435,063	For
Vanguard	16,321,717	12,417	For
Fidelity	7,532,522	0	For
Invesco	0	7,437,984	Abstain
State Street	52,817	6,167,686	Abstain
TIAA	0	3,467,129	Abstain
OBERWEIS FUNDS	3,342,600	0	For
Dimensional	2,659,880	0	For
American Century	2,409,824	0	For
Charles Schwab	2,292,684	0	For
Allspring	2,177,517	0	For
Thrivent	1,851,036	0	For
T. Rowe Price	0	1,577,442	Abstain
Jackson National	101,198	1,470,174	Abstain
Lord Abbett	1,419,766	0	For
Calamos	1,408,078	0	For
Putnam	1,366,764	0	For
Federated Hermes	1,074,813	0	For
Waddell & Reed	0	897,194	Abstain
Brighthouse	89,595	687,799	Abstain
Nuveen	0	730,657	Abstain
Equitable	364,853	256,270	For
Royce	612,241	0	For
Voya	611,399	0	For
Columbia Threadneedle	0	579,761	Abstain

Showing the 25 largest of 113 asset managers. See all 113 in the interactive database.

5. To elect the following Class III directors for a term expiring at the 2028 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Jerrold B. Grossman D.P.S.

DIRECTOR ELECTIONS

100% fund support · no official result

FOR 89%11%

The 80 asset managers below cast 100% of the shares they voted on this item FOR (64,498,677 for, 0 against).

FOR: 64,498,677 (88.6%)ABSTAIN: 8,301,359 (11.4%)

Largest asset managers voting on “To elect the following Class III directors for a term expiring at the 2028 Annual Meeting of Stockholders or u” at ADMA BIOLOGICS INC., 2024-2025
Asset manager	For	Abstain	Vote
Vanguard	16,315,104	0	For
Fidelity	7,532,522	0	For
Invesco	7,437,984	0	For
State Street	52,817	6,167,686	Abstain
TIAA	3,467,129	0	For
OBERWEIS FUNDS	3,342,600	0	For
Dimensional	2,659,880	0	For
American Century	2,409,824	0	For
Charles Schwab	2,292,684	0	For
Allspring	2,177,517	0	For
Thrivent	1,851,036	0	For
T. Rowe Price	0	1,577,442	Abstain
Lord Abbett	1,419,766	0	For
Putnam	1,366,764	0	For
Federated Hermes	1,074,813	0	For
Waddell & Reed	897,194	0	For
Nuveen	730,657	0	For
Equitable	621,123	0	For
Royce	612,241	0	For
Voya	611,399	0	For
Columbia Threadneedle	579,761	0	For
DRIEHAUS MUTUAL FUNDS	562,742	0	For
Russell Investments	556,054	0	For
AIG/SunAmerica	545,164	0	For
MassMutual	485,761	0	For

Showing the 25 largest of 80 asset managers. See all 80 in the interactive database.

6. Election of Class III Director for a term expiring at the 2028 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Jerrold B. Grossman D.P.S.

DIRECTOR ELECTIONS

100% fund support · no official result

FOR 99.8%

The 33 asset managers below cast 100% of the shares they voted on this item FOR (31,261,716 for, 0 against).

FOR: 31,261,716 (99.9%)ABSTAIN: 31,663 (0.1%)

Largest asset managers voting on “Election of Class III Director for a term expiring at the 2028 Annual Meeting of Stockholders or until their s” at ADMA BIOLOGICS INC., 2024-2025
Asset manager	For	Abstain	Vote
BlackRock	26,117,195	0	For
Jackson National	1,571,372	0	For
Calamos	1,408,078	0	For
QUANTITATIVE MASTER SERIES LLC	383,799	0	For
EA Series Trust	293,798	0	For
CARILLON SERIES TRUST	198,375	0	For
ETF Series Solutions	140,339	0	For
TRUST FOR PROFESSIONAL MANAGERS	120,862	0	For
John Hancock	120,642	0	For
Securian Funds Trust	119,740	0	For
JPMorgan	111,873	0	For
Innovator ETFs Trust	106,577	0	For
HUSSMAN INVESTMENT TRUST	105,000	0	For
Zacks Trust	84,041	0	For
Allianz	79,136	0	For
Bridge Builder Trust	44,877	27,682	For
MASTER INVESTMENT PORTFOLIO	55,813	0	For
RBC FUNDS TRUST	47,920	0	For
BUFFALO FUNDS	47,870	0	For
Exchange Place Advisors Trust	30,480	0	For
Vanguard	18,993	38	For
Northern Lights Fund Trust IV	17,612	0	For
TIMOTHY PLAN	12,320	0	For
Pacer Funds Trust	8,108	0	For
SARATOGA ADVANTAGE TRUST	5,392	0	For

Showing the 25 largest of 33 asset managers. See all 33 in the interactive database.

7. Advisory Vote on Say on Pay Frequency

SECTION 14A SAY-ON-PAY VOTES

100% fund support · no official result

FOR 49.1%ONE YEAR 50.1%

The 10 asset managers below cast 100% of the shares they voted on this item FOR (1,230,561 for, 0 against).

FOR: 1,230,561 (49.1%)ONE YEAR: 1,255,865 (50.1%)1 YEAR: 21,226 (0.8%)

Largest asset managers voting on “Advisory Vote on Say on Pay Frequency” at ADMA BIOLOGICS INC., 2024-2025
Asset manager	For	Vote
Ophir Asset Management Pty Ltd	1,154,989	For
Brighthouse	0	One Year
JPMorgan	0	One Year
Ausbil Investment Management Ltd	0	One Year
Empower	0	One Year
APG Asset Management US Inc.	0	One Year
TD ASSET MANAGEMENT INC	75,572	For
FORUM FUNDS II	0	1 Year
CLEARWATER INVESTMENT TRUST	0	One Year
Desjardins Global Asset Management Inc.	0	One Year

8. Elect Director Jerrold B. Grossman

DIRECTOR ELECTIONS

100% fund support · no official result

FOR 98%

The 4 asset managers below cast 100% of the shares they voted on this item FOR (654,430 for, 0 against).

FOR: 654,430 (98.2%)ABSTAIN: 12,296 (1.8%)

Largest asset managers voting on “Elect Director Jerrold B. Grossman” at ADMA BIOLOGICS INC., 2024-2025
Asset manager	For	Abstain	Vote
Brighthouse	451,046	0	For
Empower	182,158	0	For
FORUM FUNDS II	21,226	0	For
CLEARWATER INVESTMENT TRUST	0	12,296	Abstain

Largest ADMA BIOLOGICS INC. shareholders voting in 2024-2025

Ranked by the number of ADMA BIOLOGICS INC. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 238,532,252 shares outstanding at the time of that meeting.

Top ADMA BIOLOGICS INC. shareholders by shares voted, 2024-2025
#	Asset manager	% of shares outstanding
1	BlackRock	14.34%
2	Invesco	7.38%
3	Vanguard	7.18%
4	State Street	7.11%
5	Fidelity	4.57%
6	GEODE CAPITAL MANAGEMENT, LLC	2.39%
7	Nuveen	2.34%
8	American Century	2.21%
9	Allspring	2.13%
10	Charles Schwab	2.00%

Reported ADMA BIOLOGICS INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

ADMA BIOLOGICS INC. beneficial owners on record for the 2024-2025 proxy season
Holder	% outstanding	Disclosure
BlackRock	15.63%	13F
Vanguard Group	7.06%	13F
Invesco	5.39%	13F
State Street	4.80%	13F
Morgan Stanley	2.06%	13F
Dimensional Fund Advisors	2.04%	13F
Nuveen	1.91%	13F
Renaissance Technologies	1.49%	13F
FMR (Fidelity)	1.41%	13F

Percentages above are of 238,532,252 shares outstanding, as reported by ADMA BIOLOGICS INC. on its Form 10-Q dated 2025-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from ADMA BIOLOGICS INC.’s 10-Q dated 2025-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At ADMA BIOLOGICS INC.'s shareholder meeting held 2025-06-04, in the 2024-2025 proxy season, 363 asset managers reported how they voted in their SEC Form N-PX filings, covering 2,784 separate fund positions. Their filings are grouped here into 8 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To approve, on a non-binding, advisory basis, the compensation of the Company's named executive… — FOR was 89% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: ADMA BIOLOGICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2025-06-04.

ADMA BIOLOGICS INC. proxy season coverage: 2024-2025 (this page) · 2025-2026.